2024-11-08  5:35:00 PM Chg. -0.525 Volume Bid5:35:00 PM Ask2024-11-08 Market Capitalization Dividend Y. P/E Ratio
18.315EUR -2.79% 1.54 mill.
Turnover: 28.28 mill.
-Bid Size: - -Ask Size: - 8.53 bill.EUR 6.39% -

Business description

Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
 

Management board & Supervisory board

CEO
Christian Kullmann
Management board
Maike Schuh, Dr. Harald Schwager, Thomas Wessel
Supervisory board
Bernd Tönjes, Prof. Dr. Barbara Albert, Dr. Cornelius Baur, Prof. Dr. Aldo Belloni, Werner Fuhrmann, Dr. Christian Kohlpaintner, Cedrik Neike, Dr. Ariane Reinhart, Michael Rüdiger, Angela Titzrath, Alexander Bercht, Martin Albers, Alexandra Boy, Alexandra Krieger, Martin Kubessa, Hussin El Moussaoui, Thomas Meiers, Martina Reisch, Gerhard Ribbeheger, Gerd Schlengermann
 

Company data

Name: Evonik Industries AG
Address: Rellinghauser Straße 1-11,D-45128 Essen
Phone: +49-201-177-3315
Fax: +49-201-177-3053
E-mail: info@evonik.com
Internet: corporate.evonik.de/
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 12-31
Free Float: 44.00%
IPO date: 2013-04-25

Investor relations

Name: Tim Lange
IR phone: +49-201-177-3146
IR Fax: +49-201-177-3140
IR e-mail: investor-relations@evonik.com

Main Shareholders

RAG foundation
 
53.00%
FreeFloat
 
47.00%